AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 43 filers reported holding AIM IMMUNOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,036 | -32.1% | 2,276 | 0.0% | 0.00% | – |
| Q2 2023 | $1,525 | +55.8% | 2,276 | 0.0% | 0.00% | – |
| Q1 2023 | $979 | +1278.9% | 2,276 | 0.0% | 0.00% | – |
| Q4 2022 | $71 | -96.4% | 2,276 | -7.3% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,454 | -0.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 2,455 | +68.7% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 1,455 | -57.9% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 3,455 | +137.5% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 1,455 | +70.2% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 855 | +87.5% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 456 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 456 | +0.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 455 | +0.2% | 0.00% | – |
| Q2 2020 | $1,000 | -98.4% | 454 | -98.1% | 0.00% | – |
| Q1 2020 | $61,000 | – | 23,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,873 | $26,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 95,754 | $206,000 | 0.03% |
| Arkadios Wealth Advisors | 20,000 | $45,400,000 | 0.02% |
| Bayesian Capital Management, LP | 42,200 | $91,000 | 0.02% |
| SeaCrest Wealth Management, LLC | 50,515 | $109,000 | 0.02% |
| Virtu Financial LLC | 29,604 | $64,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $31,000 | 0.01% |
| WEDBUSH SECURITIES INC | 13,295 | $29,000 | 0.00% |
| Verition Fund Management LLC | 40,000 | $86,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11,600 | $25,000 | 0.00% |